The Foundation Routine: Why GHK-Cu and BPC-157 Work Together
Two peptides. Two mechanisms. One comprehensive approach to the most common causes of hair loss. This is why the Foundation Routine is the right starting point.
When we designed the Foundation Routine, we had one goal: maximum impact with minimum complexity for someone beginning a peptide hair protocol.
GHK-Cu and BPC-157 were the clear answer. Not because they are the newest or most novel compounds, but because they address the two primary biological failures that drive most hair loss.
The Two Root Problems
Decades of pathological research on androgenetic alopecia reveal two consistent upstream failures:
1. Follicle miniaturization via reduced growth signals. Dermal papilla cells produce IGF-1, VEGF, and other paracrine factors that support follicle cycling. In AGA, DHT gradually reduces this production. Without adequate growth signals, follicles produce progressively thinner, shorter hairs until they cease production entirely.
2. Scalp vasculature decline. Blood flow to balding scalp regions is measurably lower than to non-balding regions. The capillary networks that supply follicles regress. Follicles are physically starved of the nutrients, oxygen, and circulating growth factors they need to function.
GHK-Cu Addresses Problem #1
GHK-Cu restores follicle growth signaling through Wnt/β-catenin activation. This pathway controls: - Hair follicle stem cell activation - Dermal papilla cell proliferation - Anagen phase duration - Follicle size and hair shaft caliber
It also directly stimulates IGF-1 and VEGF expression in follicle-supporting cells, partially restoring the paracrine signaling environment that DHT has degraded.
BPC-157 Addresses Problem #2
BPC-157's dominant mechanism in hair biology is angiogenesis. It activates the FAK-paxillin signaling pathway and upregulates VEGFR2 on endothelial cells, driving the formation of new capillaries around follicle structures.
Restored vasculature means: - More oxygen at the follicle base - Direct delivery of circulating IGF-1 and growth hormone - Clearance of DHT metabolites and inflammatory cytokines from the follicle environment
Why the Combination Outperforms Either Alone
GHK-Cu and BPC-157 are not redundant — they are complementary. GHK-Cu reactivates the follicle's internal machinery. BPC-157 rebuilds the external infrastructure that supports it. Both upregulate VEGF, making their combined effect greater than either alone.
Clinical observation across users consistently shows: - Faster results compared to either peptide alone - Better retention of gains over time - Wider coverage (both structural and vascular problems addressed)
Start with the Foundation Routine for a full 12 weeks before considering additions. Most users see meaningful improvement within this window without needing to advance to the full protocol.